An approach to medicine based on grouping patients according to the characteristics of their disease or how they respond to particular treatments (or to prophylaxis). This enables the identification and development of measures that are most effective for particular groups of patients.
Patients diagnosed with breast cancer may be able to safely avoid chemotherapy if a genomic test indicates they are at low risk of their cancer returning, according to findings presented at a major cancer conference...
A long-term clinical trial of a gene therapy for a rare genetic form of deafness has demonstrated sustained hearing restoration, while a separate gene therapy for the same condition has received approval from the Food and Drug Administration...
What if personalised medicine – designed to be more precise – actually ends up being less fair, asks Dr Tsveti Stoilova...
A lab-grown oesophagus has been successfully transplanted into pigs for the first time, restoring normal swallowing in the animals...
A new gene-targeted drug therapy has shown promise in reducing seizures for patients with a rare genetic childhood epilepsy...
Not all mutations in the CTNNB1 gene — a key cancer driver — are equal, offering insights for personalised cancer treatment...
A new analysis offers the most comprehensive map of large scale genomic variants in the Qatari population...
A patient with B-cell acute lymphoblastic leukaemia has become the first adult to receive a pioneering cell therapy on the NHS...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
